Publications

Costs and Cost-Effectiveness of Biomedical, Non-Surgical HIV Prevention Interventions: A Systematic Literature Review.

BOZZANI, FM; TERRIS-PRESTHOLT, F; Quaife, M; GAFOS, M; INDRAVUDH, PP; Giddings, R; MEDLEY, GF; Malhotra, S; TORRES-RUEDA, S;

2022

PharmacoEconomics, (2022).41 5 10.1007/s40273-022-01223-w.

Reimagining health systems as systems for health.

Marten, R; Shroff, ZC; HANSON, K; Davies, S; Reddy, S; Vega, J; Peters, DH; Ghaffar, A;

2022

BMJ (Clinical research ed.), (2022).379, 10.1136/bmj.o3025.

Potential benefit of extended dose schedules of human papillomavirus vaccination in the context of scarce resources and COVID-19 disruptions in low-income and middle-income countries: a mathematical modelling analysis.

Bénard, É; Drolet, M; Laprise, J-F; JIT, M; PREM, K; Boily, M-C; Brisson, M;

2022

The Lancet Global health, (2022).11 1 10.1016/S2214-109X(22)00475-2.

Cost-Effectiveness of Risk-Reducing Surgery for Breast and Ovarian Cancer Prevention: A Systematic Review.

WEI, X; Oxley, S; Sideris, M; Kalra, A; SUN, L; Yang, L; LEGOOD, R; Manchanda, R;

2022

Cancers, (2022).14 24 10.3390/cancers14246117.

Cost-effectiveness of short, oral treatment regimens for rifampicin resistant tuberculosis.

SWEENEY, S; Berry, C; Kazounis, E; Motta, I; VASSALL, A; DODD, M; FIELDING, K; NYANG'WA, B-T;

2022

PLOS Global Public Health, (2022).2 12 10.1371/journal.pgph.0001337.

Regional citrate anticoagulation versus systemic heparin anticoagulation for continuous kidney replacement therapy in intensive care.

Doidge, JC; Gould, DW; SADIQUE, Z; Borthwick, M; Hatch, RA; Caskey, FJ; Forni, L; Lawrence, RF; MacEwan, C; Ostermann, M; Mouncey, PR; Harrison, DA; Rowan, KM; Young, JD; Watkinson, PJ;

2022

Journal of critical care, (2022).74, 10.1016/j.jcrc.2022.154218.

Cost-effectiveness of PRACTECAL regimens for MDR-TB.

SWEENEY, S;

2022

(2022).

Equity analysis of the impacts of COVID-19 strategies across six countries.

SWEENEY, S;

2022

(2022).

How does power shape district health management team responsiveness to public feedback in low- and middle-income countries: an interpretive synthesis.

Kagwanja, N; Molyneux, S; Whyle, E; Tsofa, B; GILSON, L;

2022

Health policy and planning, (2022).38 4 10.1093/heapol/czac105.

Exploring uncertainty and use of real-world data in the National Institute for Health and Care Excellence single technology appraisals of targeted cancer therapy.

KANG, J; CAIRNS, J;

2022

BMC cancer, (2022).22 1 10.1186/s12885-022-10350-8.